If you are looking for a supplier or manufacturer of Fimasartan (CAS No.: 247257-48-3) please contact us. We have more than 10 years of experience in custom synthesis of compounds. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Fimasartan (CAS No.: 247257-48-3) and other compounds. We can provide high-quality compounds and good service for you.
Name |
Fimasartan |
Synonyms |
2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide; 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide;FIMASARTAN;BR-A-657K |
Molecular Formula |
C27H31N7OS |
Molecular Weight |
424.49000 |
CAS Number |
247257-48-3 |
purity |
≥98% |
Storage conditions |
Sealed in dry,2-8°C |
Application:Fimasartan (CAS No.: 247257-48-3) is a non-peptide angiotensin
II receptor antagonist (ARB) used for the treatment of hypertension and heart
failure. Through oral administration, fimasartan blocks angiotensin II receptor
type 1 (AT1 receptors), reducing pro-hypertensive actions of angiotensin II,
such as systemic vasoconstriction and water retention by the kidneys.
Concurrent administration of fimasartan with diuretic hydrochlorothiazide has
shown to be safe in clinical trials. Fimasartan was approved for use in South
Korea in September 9, 2010 and is available under the brand name Kanarb through
Boryung Pharmaceuticals, who are presently seeking worldwide partnership.